Jonathan Spergel
Pediatric Allergy/Immunology · Philadelphia, PANPI 1043226996
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Sanofi at 48.9% of the total. Among pediatric allergy/immunology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 257 payments — averaging $1469.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$185K
- Sanofi-aventis U.S. LLC$32K
- Regeneron$32K
- Novartis$26K
- Takeda Pharmaceuticals U.S.A., Inc.$20K
- E.r. Squibb & Sons, L.L.C.$14K
- plus $69K from 15 others
Across 407 payments — averaging $5602.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2M
- ARS Pharmaceuticals Operations, Inc.$81K
- Sanofi US Services Inc.$66K
- AstraZeneca$65K
- Aimmune Therapeutics, Inc.$65K
- Bristol Myers Squibb$22K
- plus $22K from 3 others
What the payments were for
- Consulting fees$172,46246%
- Speaking & faculty fees$139,65037%
- Travel & lodging$60,25716%
- Food & beverage$4,5951%
- Education$7150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 127 | $184,757 |
| Sanofi-aventis U.S. LLC | 11 | $31,860 |
| Regeneron | 20 | $31,598 |
| Novartis | 13 | $25,790 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $20,420 |
| E.r. Squibb & Sons, L.L.C. | 8 | $14,358 |
| Regeneron Healthcare Solutions, Inc. | 9 | $13,569 |
| Merck | 14 | $11,080 |
| Eli Lilly | 2 | $9,200 |
| LEO Pharma Inc. | 3 | $6,665 |
| Incyte Corporation | 12 | $6,567 |
| AstraZeneca | 18 | $5,311 |
| Shire North American Group Inc | 2 | $4,620 |
| Bristol Myers Squibb | 2 | $2,719 |
| Sarepta Therapeutics, Inc. | 1 | $2,707 |
| Astrazeneca UK Limited | 1 | $2,626 |
| Kaleo, Inc. | 2 | $2,562 |
| AbbVie | 1 | $575 |
| Janssen Research & Development, LLC | 1 | $450 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $154 |
| GSK | 1 | $93 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$377,679 in reported general payments places this provider in the 95th percentile of 34 pediatric allergy/immunology providers in Pennsylvania.
See all pediatric allergy/immunology providers in Pennsylvania →
Other pediatric allergy/immunology in Philadelphia
- Antonella CianferoniPhiladelphia$71K
- Jennifer HeimallPhiladelphia$48K
- Sarah HenricksonPhiladelphia$14K
- Kathleen SullivanPhiladelphia$8K
- Neil RombergPhiladelphia$2K
- Rushani SaltzmanPhiladelphia$1K
- Talia ArceriPhiladelphia$1K
- Daniel ConwayPhiladelphia$960
- Soma JyonouchiPhiladelphia$492
- Katie KennedyPhiladelphia$485
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.